Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05199792 · ClinicalTrials.gov registry record
Efficacy of Gadoterate Meglumine in Diagnosis of Vascular Diseases Using MRA MRA
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 65
- Enrollment target
NCT05199792 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 65 participants.
The verdict
NCT05199792 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
The purpose of this study is to compare magnetic resonance angiography (MRA) using gadoterate meglumine to clinically obtained MRA using gadobutrol. The specific aims are to show: 1. Carotid, chest, and abdomenal MRA with gadoterate meglumine has a comparable image quality and diagnostic confidence to MRA using gadobutrol. 2. Carotid, chest, and abdomenal MRA with gadoterate meglumine has a comparable accuracy for vascular lesion and stenosis detection compared to MRA using gadobutrol.
Interventions
- DIAGNOSTIC_TEST Dotarem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2017-06-02 |
| Est. Completion | 2020-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05199792
The ClinicalTrials.gov registry entry for NCT05199792 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dotarem is the first listed.
NCT05199792 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05199792 about?
NCT05199792 is a clinical study titled "Efficacy of Gadoterate Meglumine in Diagnosis of Vascular Diseases Using MRA MRA". The purpose of this study is to compare magnetic resonance angiography (MRA) using gadoterate meglumine to clinically obtained MRA using gadobutrol. The specific aims are to show: 1. Carotid, chest, and abdomenal MRA with gadoterate meglumine has a comparable image quality and diagnostic confidence...
What is the current status of trial NCT05199792?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2017-06-02. Estimated completion is 2020-01-01.
What interventions are being tested in trial NCT05199792?
The interventions under investigation include: Dotarem (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05199792?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.